Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-02-27 @ 2:20 PM
Study NCT ID:
NCT01745094
Status:
COMPLETED
Last Update Posted:
2018-02-28
First Post:
2012-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2013-07-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07-23
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-06
First Submit QC Date:
None
Study First Post Date:
2012-12-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-10
Results First Submit QC Date:
None
Results First Post Date:
2018-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-31
Last Update Post Date:
2018-02-28
Last Update Post Date Type:
ACTUAL